EnVVeno Medical Appoints Sandy Prietto as VP of Marketing

enVVeno Medical Corporation has announced the addition of Sandy Prietto as its Vice President of Marketing. With years of experience in medical device marketing, Prietto has successfully launched new products at Endologix and Edwards Lifesciences.

This strategic hire comes as enVVeno prepares for the commercialization of its VenoValve. Scheduled milestones for Q4 2024 include the completion of PMA submission for FDA approval, the release of one-year data from the VenoValve U.S. pivotal study, and the start of a pre-clinical study for enVVe.

enVVeno’s lead product, the VenoValve, is designed to treat severe Chronic Venous Insufficiency (CVI). Prietto's recent role at Endologix included launching the DETOUR system, marking her as a valuable asset for enVVeno’s upcoming projects.